Answers are grounded in this paper and cite their sources.
The duodenal-jejunal bypass liner (DJBL) shows efficacy in facilitating weight loss and improving metabolic parameters in obese patients with T2DM, though further research on long-term outcomes and management of adverse events is needed.
No takes yet. Share an insight, caveat, or question.
Tripdatabase (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: